Skip to main content
. 2020 Dec 17;8:100307. doi: 10.1016/j.ejro.2020.100307

Table 3.

Performance of ABB-MRI protocols in screening settings for women at high-risk of breast cancer.

Study Lesions Cancers/ Subjects Reference Readers Exper. (years) Sens. Spec. PPV PNV Agree.
Grimm et al. [35] 24 12/48 Biopsy/ follow-up 3 714 86 86
Harvey et al. [46] 7/505 Biopsy 122 89 45
Panigrahi et al. [50] 49 14/1052 Biopsy 10 122 81.8 97.2 30.4 0.94
Romeo et al. [39] 180 64/98 Biopsy/ follow-up 2 816 97 95 95 98
Seppala et al. [53] 56 23/100 Biopsy 3 622 69.6 77.9 0.540.53
Zelst et al. [65] 85 31/100 Biopsy/ follow-up 7 615 84 82 45 0.73
Dialani et al. [55] 7/259 7/259 Biopsy/ follow-up 5 428 77
81



91
76



91 89
Jones et al. [56] 56 56/125 Biopsy/ follow-up 8 228 88 87 0.660.63
Marquina et al. [59] 12 11/82 Biopsy/ follow-up 1 >10 100 91.43 47.83 100
Scoggins et al. [62] 20 6/73 Biopsy/ follow-up 16 127 100
73.6
5
100
0.68
100
77.8
5.9
100
0.51
100 93 16.7 100 0.37